Altered brain lipid composition in cyclooxygenase-2 knockout mouse

Journal of Lipid Research

Volumn 48, Issue 4, 2007, Pages 848-854

  Ma, Kaizong ^a   Langenbach, Robert ^b   Rapoport, Stanley I ^a   Basselin, Mireille ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cholesterol; Fatty acids; Phosphatidylserine

Indexed keywords

ACYL COENZYME A; ANANDAMIDE; ARACHIDONIC ACID; CHOLESTEROL; CYCLOOXYGENASE 2; FATTY ACID; GLUTAMIC ACID; ICOSANOID; LIPID; PALMITIC ACID; PHOSPHATIDYLSERINE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; BRAIN; CONTROLLED STUDY; EXCITOTOXICITY; INFLAMMATION; LIPID COMPOSITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN CHEMISTRY; CYCLOOXYGENASE 2; FATTY ACIDS; LIPID METABOLISM; LIPIDS; MICE; MICE, KNOCKOUT;

EID: 34147169865     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600400-JLR200     Document Type: Article

References (66)

1. Needleman, P., J. Turk, B. A. Jakschik, A. R. Morrison, and J. B. Lefkowith. 1986. Arachidonic acid metabolism. Annu. Rev. Biochem. 55: 69-102.
2. Otto, J. C., and W. L. Smith. 1995. Prostaglandin endoperoxide synthases-1 and -2. J. Lipid Mediat. Cell Signal. 12: 139-156.
3. Kaufmann, W. E., P. F. Worley, J. Pegg, M. Bremer, and P. Isakson. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. USA. 93: 2317-2321.
4. Yamagata, K., K. I. Andreasson, W. E. Kaufmann, C. A. Barnes, and P. F. Worley. 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11: 371-386.
5. Basselin, M., N. E. Villacreses, R. Langenbach, K. Ma, J. M. Bell, and S. I. Rapoport. 2006. Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mice. J. Neurochem. 96: 669-679.
6. Mirjany, M., L. Ho, and G. M. Pasinetti. 2002. Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J. Pharmacol. Exp. Ther. 301: 494-500.
7. Kelley, K. A., L. Ho, D. Winger, J. Freire-Moar, C. B. Borelli, P. S. Aisen, and G. M. Pasinetti. 1999. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. 155: 995-1004.
8. Consilvio, C., A. M. Vincent, and E. L. Feldman. 2004. Neuroinflammation, COX-2, and ALS - a dual role? Exp. Neurol. 187: 1-10.
9. Sasaki, T., K. Kitagawa, S. Sugiura, E. Omura-Matsuoka, S. Tanaka, Y. Yagita, H. Okano, M. Matsumoto, and M. Hori. 2003. Implication of cyclooxygenase-2 on enhanced proliferation of neural progenitor cells in the adult mouse hippocampus after ischemia. J. Neurosci. Res. 72: 461-471.
10. Minghetti, L. 2004. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63: 901-910.
11. Morham, S. G., R. Langenbach, C. D. Loftin, H. F. Tiano, N. Vouloumanos, J. C. Jennette, J. F. Mahler, K. D. Kluckman, A. Ledford, C. A. Lee, et al. 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83: 473-482.
12. Iadecola, C., K. Niwa, S. Nogawa, X. Zhao, M. Nagayama, E. Araki, S. Morham, and M. E. Ross. 2001. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. USA. 98: 1294-1299.
13. Shimizu, T., and L. S. Wolfe. 1990. Arachidonic acid cascade and signal transduction. J. Neurochem. 55: 1-15.
14. 2. J. Biol. Chem. 274: 11660-11666.
15. 2. J. Neurochem. 91: 1389-1397.
16. Bazinet, R. P., H. J. Lee, C. C. Felder, A. C. Porter, S. I. Rapoport, and T. A. Rosenberger. 2005. Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem. Res. 30: 597-601.
17. Deutsch, J., S. I. Rapoport, and A. D. Purdon. 1997. Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 22: 759-765.
18. Cenedella, R. J., C. Galli, and R. Paoletti. 1975. Brain free fatty levels in rats sacrificed by decapitation versus focused microwave irradiation. Lipids. 10: 290-293.
19. Bosisio, E., C. Galli, G. Galli, S. Nicosia, C. Spagnuolo, and L. Tosi. 1976. Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex and cerebellum. Prostaglandins. 11: 773-781.
20. Poddubiuk, Z. M., J. B. Blumberg, and I. J. Kopin. 1982. Brain prostaglandin content in rats sacrificed by decapitation vs focused microwave irradiation. Experientia. 38: 987-988.
21. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
22. Skipski, V. P., J. J. Good, M. Barclay, and R. B. Reggio. 1968. Quantitative analysis of simple lipid classes by thin-layer chromatography. Biochim. Biophys. Acta. 152: 10-19.
23. Makrides, M., M. A. Neumann, R. W. Byard, K. Simmer, and R. A. Gibson. 1994. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 60: 189-194.
24. DeMar, J. C., Jr., K. Ma, J. M. Bell, and S. I. Rapoport. 2004. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91: 1125-1137.
25. Rouser, G., A. N. Siakotos, and S. Fleischer. 1966. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids. 1: 85-86.
26. 2 knockout mouse. J. Lipid Res. 44: 109-117.
27. Lomnitski, L., L. Oron, D. Sklan, and D. M. Michaelson. 1999. Distinct alterations in phospholipid metabolism in brains of apolipoprotein E-deficient mice. J. Neurosci. Res. 58: 586-592.
28. Nakashima, S., K. Nagata, Y. Banno, T. Sakiyama, T. Kitagawa, S. Miyawaki, and Y. Nozawa. 1984. A mouse model for Niemann-Pick disease: phospholipid class and fatty acid composition of various tissues. J. Lipid Res. 25: 219-227.
29. Rosenberger, T. A., J. T. Hovda, and J. M. Peters. 2002. Targeted disruption of peroxisomal proliferator-activated receptor β (δ) results in distinct gender differences in mouse brain phospholipid and esterified FA levels. Lipids. 37: 495-500.
30. Rosenberger, T. A., J. Oki, A. D. Purdon, S. I. Rapoport, and E. J. Murphy. 2002. Rapid synthesis and turnover of brain microsomal ether phospholipids in the adult rat. J. Lipid Res. 43: 59-68.
31. Demar, J. C., Jr., K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport. 2005. Alpha-linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94: 1063-1076.
32. Golovko, M. Y., J. T. Hovda, Z. J. Cai, W. J. Craigen, and E. J. Murphy. 2005. Tissue-dependent alterations in lipid mass in mice lacking glycerol kinase. Lipids. 40: 287-293.
33. Ballou, L. R., R. M. Botting, S. Goorha, J. Zhang, and J. R. Vane. 2000. Nociception in cyclooxygenase isozyme-deficient mice. Proc. Natl. Acad. Sci. USA. 97: 10272-10276.
34. 2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region. Neurosci. Res. 56: 103-110.
35. Cook, H. W. 1981. Metabolism of triacylglycerol in developing rat brain. Neurochem. Res. 6: 1217-1229.
36. Rowe, C. E. 1969. The measurement of triglyceride in brain and the metabolism of brain triglyceride in vitro. J. Neurochem. 16: 205-214.
37. Sun, G. Y., S. Aradottir, L. Gustavsson, and C. Alling. 1989. Ethanol alters the transfer of arachidonic acid to ethanolamine plasmalogens in C-6 glioma cells. J. Neurosci. Res. 24: 268-275.
38. Yoshida, S., M. Ikeda, R. Busto, M. Santiso, E. Martinez, and M. D. Ginsberg. 1986. Cerebral phosphoinositide, triacylglycerol, and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J. Neurochem. 47: 744-757.
39. Zhang, J. P., and G. Y. Sun. 1995. Free fatty acids, neutral glycerides, and phosphoglycerides in transient focal cerebral ischemia. J. Neurochem. 64: 1688-1695.
40. Shinitzky, M., and P. Henkart. 1979. Fluidity of cell membranes-current concepts and trends. Int. Rev. Cytol. 60: 121-147.
41. Slotte, J. P., and E. L. Bierman. 1988. Depletion of plasmamembrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem. J. 250: 653-658.
42. Gupta, A. K., and H. Rudney. 1991. Plasma membrane sphingomyelin and the regulation of HMG-CoA reductase activity and cholesterol biosynthesis in cell cultures. J. Lipid Res. 32: 125-136.
43. Hajjar, D. P., B. B. Weksler, D. J. Falcone, J. M. Hefton, K. Tack-Goldman, and C. R. Minick. 1982. Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J. Clin. Invest. 70: 479-488.
44. Farooqui, A. A., L. A. Horrocks, and T. Farooqui. 2000. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids. 106: 1-29.
45. Vance, J. E., and R. Steenbergen. 2005. Metabolism and functions of phosphatidylserine. Prog. Lipid Res. 44: 207-234.
46. Butler, M., and P. Morell. 1983. The role of phosphatidylserine decarboxylase in brain phospholipid metabolism. J. Neurochem. 41: 1445-1454.
47. Percy, A. K., J. F. Moore, M. A. Carson, and C. J. Waechter. 1983. Characterization of brain phosphatidylserine decarboxylase: localization in the mitochondrial inner membrane. Arch. Biochem. Biophys. 223: 484-494.
48. Murakami, M., and I. Kudo. 2004. Secretory phospholipase A2. Biol. Pharm. Bull. 27: 1158-1164.
49. Mozzi, R., S. Buratta, and G. Goracci. 2003. Metabolism and functions of phosphatidylserine in mammalian brain. Neurochem. Res. 28: 195-214.
50. Bittova, L., R. V. Stahelin, and W. Cho. 2001. Roles of ionic residues of the C1 domain in protein kinase Cα activation and the origin of phosphatidylserine specificity. J. Biol. Chem. 276: 4218-4226.
51. Conesa-Zamora, P., M. J. Lopez-Andreo, J. C. Gómez- Fernández, and S. Corbalán-García. 2001. Identification of the phosphatidylserine binding site in the C2 domain that is important for PKCα activation and in vivo cell localization. Biochemistry. 40: 13898-13905.
52. Newton, A. C., and D. E. Koshland, Jr. 1990. Phosphatidylserine affects specificity of protein kinase C substrate phosphorylation and autophosphorylation. Biochemistry. 29: 6656-6661.
53. Gagne, J., C. Giguere, G. Tocco, M. Ohayon, R. F. Thompson, M. Baudry, and G. Massicotte. 1996. Effect of phosphatidylserine on the binding properties of glutamate receptors in brain sections from adult and neonatal rats. Brain Res. 740: 337-345.
54. Sunshine, C., and M. G. McNamee. 1992. Lipid modulation of nicotinic acetylcholine receptor function: the role of neutral and negatively charged lipids. Biochim. Biophys. Acta. 1108: 240-246.
55. Yamatoya, H., M. Sakai, and S. Kudo. 2000. The effects of soybean transphosphatidylated phosphatidylserine on cholinergic synaptic functions of mice. Jpn. J. Pharmacol. 84: 93-96.
56. Toffano, G., A. Leon, S. Mazzari, G. Savoini, S. Teolato, and P. Orlando. 1978. Modification of noradrenergic hypothalamic system in rat injected with phosphatidylserine liposomes. Life Sci. 23: 1093-1101.
57. 2+ uptake by rat brain synaptosomes. Arch. Biochem. Biophys. 285: 116-119.
58. Loeb, C., U. M. Marinari, E. Benassi, G. Besio, D. Cottalasso, A. Cupello, M. Maffini, P. Mainardi, M. A. Pronzato, and P. A. Scotto. 1988. Phosphatidylserine increases in vivo the synaptosomal uptake of exogenous GABA in rats. Exp. Neurol. 99: 440-446.
59. Wells, K., A. A. Farooqui, L. Liss, and L. A. Horrocks. 1995. Neural membrane phospholipids in Alzheimer disease. Neurochem. Res. 20: 1329-1333.
60. Schmitt, A., K. Wilczek, K. Blennow, A. Maras, A. Jatzko, G. Petroianu, D. F. Braus, and W. F. Gattaz. 2004. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol. Psychiatry. 56: 41-45.
61. Ohler, B., K. Graf, R. Bragg, T. Lemons, R. Coe, C. Genain, J. Israelachvili, and C. Husted. 2004. Role of lipid interactions in autoimmune demyelination. Biochim. Biophys. Acta. 1688: 10-17.
62. Brooksbank, B. W., and M. Martínez. 1989. Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease. Mol. Chem. Neuropathol. 11: 157-185.
63. Lukacova, N., M. Gottlieb, and J. Marsala. 1998. Lipid peroxidation and phospholipid composition in rat brain regions after ischemia and in early perfusion periods. Arch. Ital. Biol. 136: 167-180.
64. Adibhatla, R. M., J. F. Hatcher, and R. J. Dempsey. 2001. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke. 32: 2376-2381.
65. Suzuki, S., M. Furushiro, M. Takahashi, M. Sakai, and S. Kudo. 1999. Oral administration of soybean lecithin transphosphatidylated phosphatidylserine (SB-tPS) reduces ischemic damage in the gerbil hippocampus. Jpn. J. Pharmacol. 81: 237-239.
66. Shetty, H. U., Q. R. Smith, K. Washizaki, S. I. Rapoport, and A. D. Purdon. 1996. Identification of two molecular species of rat brain phosphatidylcholine that rapidly incorporate and turn over arachidonic acid in vivo. J. Neurochem. 67: 1702-1710.